HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.

Abstract
Approximately 25-30% of childhood pre-B cell acute lymphoblastic leukemias (pre-B ALL) is characterized by the presence of a (1;19)(q23;p13.3) translocation. The presence of this translocation is generally accompanied by a poor prognosis. The chimeric gene resulting from this chromosomal rearrangement encodes a hybrid transcription factor, E2A-Pbx1. In an attempt to delineate the genetic cascade initiated by E2A-Pbx1, we sought to identify genes that are deregulated by this transcription factor in t(1;19) pre-B ALL. We show here that the gene encoding the granulocyte colony-stimulating factor receptor (G-CSFr) is specifically upregulated in pre-B cells expressing E2A-Pbx1. G-CSFr is also expressed in cell lines established from t(1;19) pre-B cell leukemia and on primary t(1;19) tumor cells, but not on control cells. These data indicate that G-CSFr gene is a target for deregulation by E2A-Pbx1.
AuthorsW B de Lau, J Hurenkamp, P Berendes, I P Touw, H C Clevers, M A van Dijk
JournalOncogene (Oncogene) Vol. 17 Issue 4 Pg. 503-10 (Jul 30 1998) ISSN: 0950-9232 [Print] England
PMID9696044 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Homeodomain Proteins
  • Oncogene Proteins, Fusion
  • Receptors, Granulocyte Colony-Stimulating Factor
  • E2A-Pbx1 fusion protein
Topics
  • B-Lymphocytes
  • Burkitt Lymphoma (genetics, metabolism)
  • Chromosomes, Human, Pair 1
  • Chromosomes, Human, Pair 19
  • Gene Expression Regulation
  • Hematopoietic Stem Cells
  • Homeodomain Proteins (genetics, metabolism)
  • Humans
  • Oncogene Proteins, Fusion (genetics, metabolism)
  • Receptors, Granulocyte Colony-Stimulating Factor (genetics, physiology)
  • Translocation, Genetic
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: